Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD
2013 ◽
Vol 14
(6)
◽
pp. 775-781
◽
2015 ◽
Vol 9
(2)
◽
pp. 56-68
Keyword(s):
2021 ◽
Vol 9
(1)
◽
pp. 1929757
2020 ◽
Vol Volume 15
◽
pp. 1529-1543